| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13065* | 2021 |
| The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants KW Pajtler, SC Mack, V Ramaswamy, CA Smith, H Witt, A Smith, ... Acta neuropathologica 133, 5-12, 2017 | 311 | 2017 |
| Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma H Nikbakht, E Panditharatna, LG Mikael, R Li, T Gayden, M Osmond, ... Nature communications 7 (1), 11185, 2016 | 240 | 2016 |
| A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy X Du, F Tang, M Liu, J Su, Y Zhang, W Wu, M Devenport, CA Lazarski, ... Cell research 28 (4), 416-432, 2018 | 230 | 2018 |
| Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ... Cancer cell 30 (6), 891-908, 2016 | 229 | 2016 |
| Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ... Journal of clinical oncology 34 (21), 2468-2477, 2016 | 192 | 2016 |
| Pediatric low-grade gliomas: implications of the biologic era RJ Packer, S Pfister, E Bouffet, R Avery, P Bandopadhayay, M Bornhorst, ... Neuro-oncology 19 (6), 750-761, 2017 | 163 | 2017 |
| CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity T Spence, P Sin-Chan, D Picard, M Barszczyk, K Hoss, M Lu, SK Kim, ... Acta neuropathologica 128, 291-303, 2014 | 163 | 2014 |
| Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy E Panditharatna, LB Kilburn, MS Aboian, M Kambhampati, ... Clinical Cancer Research 24 (23), 5850-5859, 2018 | 154 | 2018 |
| Long‐term efficacy and toxicity of bevacizumab‐based therapy in children with recurrent low‐grade gliomas EI Hwang, RI Jakacki, MJ Fisher, LB Kilburn, M Horn, G Vezina, BR Rood, ... Pediatric blood & cancer 60 (5), 776-782, 2013 | 139 | 2013 |
| Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab RA Avery, EI Hwang, RI Jakacki, RJ Packer JAMA ophthalmology 132 (1), 111-114, 2014 | 118 | 2014 |
| Heterogeneity within the PF-EPN-B ependymoma subgroup FMG Cavalli, JM Hübner, T Sharma, B Luu, M Sill, M Zapotocky, SC Mack, ... Acta neuropathologica 136, 227-237, 2018 | 102 | 2018 |
| Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups DM Merino, A Shlien, A Villani, M Pienkowska, S Mack, V Ramaswamy, ... Clinical Cancer Research 21 (1), 184-192, 2015 | 93 | 2015 |
| Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the children’s oncology group … EI Hwang, M Kool, PC Burger, D Capper, L Chavez, S Brabetz, ... Journal of clinical oncology 36 (34), 3388-3395, 2018 | 88 | 2018 |
| Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study BK Li, A Vasiljevic, C Dufour, F Yao, BLB Ho, M Lu, EI Hwang, ... Acta neuropathologica 139, 223-241, 2020 | 86 | 2020 |
| Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid AM Saratsis, S Yadavilli, S Magge, BR Rood, J Perez, DA Hill, E Hwang, ... Neuro-oncology 14 (5), 547-560, 2012 | 86 | 2012 |
| Efficacy of carboplatin and isotretinoin in children with high-risk medulloblastoma: a randomized clinical trial from the Children’s Oncology Group SES Leary, RJ Packer, Y Li, CA Billups, KS Smith, A Jaju, L Heier, ... JAMA oncology 7 (9), 1313-1321, 2021 | 82 | 2021 |
| A C19MC-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs: a lethal brain tumor P Sin-Chan, I Mumal, T Suwal, B Ho, X Fan, I Singh, Y Du, M Lu, N Patel, ... Cancer cell 36 (1), 51-67. e7, 2019 | 81 | 2019 |
| An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN) M DeWire, M Fouladi, DC Turner, C Wetmore, C Hawkins, C Jacobs, ... Journal of neuro-oncology 123, 85-91, 2015 | 67 | 2015 |
| Handheld optical coherence tomography during sedation in young children with optic pathway gliomas RA Avery, EI Hwang, H Ishikawa, MT Acosta, KA Hutcheson, D Santos, ... JAMA ophthalmology 132 (3), 265-271, 2014 | 66 | 2014 |
